The modulating processes of dietary vegetable protein and polyunsaturated fatty acids (PUFAs) on cholesterol (CH) metabolism are very complicated. Since dietary protein can affect PUFA absorption and synthesis through the effects of its amino acid components, the CH-lowering of PUFAs may be modulated by dietary proteins. The effect of dietary PUFAs on the CH-lowering mechanism of vegetable proteins is mainly additive and complementary, but not competitive. Dietrary vegetable protein reduces intestinal CH absorption, enhances catabolism of the CH-carrying lipopro teins, increases the LDL receptor activity, and modulates CH metabolic enzymes through the amino acid-modulated action of hormones. PUFAs may modulate CH metabolism through the action of eicosanoids which modulates the activity of the enzymes responsible for CH metabolism.
Similarly, CH-feeding suppresses hepatic D6D and D5D activity (6) . This inhibitory effect reduces not only the synthesis but also the high CH-lowering potency of GLA, DGLA, and AA (7). However, concomit feeding of CH and vegetable protein to animals does not induce a cumulative suppression on desaturase activity. We have instead, observed an alleviation in the CH-induced inhibition of D5D activity in the soy protein-fed as compared with those in the casein-fed rats (8) . This might be attributed to a reduced tissue CH contents which minimizes the CH-induced inhibition on PUFA metabolism.
Effect of Dietary Proteins and PUFAs on CH Metabolism
The present report gethers evidence and examines whether dietary PUFAs provide an additive, competitive or complementary action to S169 the CH-lowering effects of dietary vegetable proteins, and the possible action sites over which these 2 nutrients might interact with each other. I
. Absorption and excretion of cholesterol and bile acids Protein quality has significant effect on CH absorption. Vahouny et al. (9) have shown that dietary casein, as compared to soy protein increase CH absorption, and addition of arginine to casein diet reduced, while addition of lysine to the soy diet increased the rate of CH and fatty acid absorption. The effect of dietary fats on CH absorption on the other hand, is regulated by the quantity and not by the quality (degree of unsaturation) of the fats.
Dietary proteins also affect fecal steroid excretion in animals. Vegetable protein-feeding as compared with casein-feeding increases the fecal steroid excretion. This reduces the intestinal absorption and subsequently the serum CH levels. It has been suggested that the undigested vegetable protein residues may interrupt the enterohepatic reabsorption of steroids (10).
II. CH metabolic enzymes 1) HMG-CoA reductase In animals, 3 hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase is the rate-limiting enzyme for CH biosynthesis. In case of low CH intake, tissues synthesize CH to meet the needs. Cholesterol accumulation on the other hand, inhibits CH synthesis by feedback regulation. In soybean protein-fed rats, a significant fraction of CH and bile acids in the intestinal lumen, is excreted into feces. This enhances the activity of HMG-CoA reductase to synthesize CH in order to compensate for the loss of steroids. On the other hand, dietary casein which increases CH absorption, markedly decreased the hepatic CH biosynthesis in rats (11) . The effects of dietary fats on CH metabolism is less conclusive. While some reports shown that saturated fats increase the hepatic CH synthesis, the others demonstrated that dietary fats have no effect on hepatic HMG-CoA reductase activity. 
4) LCAT
In peripheral tissues, free CH migrate to membranes, where they are removed by plasma apoprotein A-I and esterified by lecithin cholesterol acyltransfereas (LCAT) into CE. Both LACT and apoprotein A-I, a LCAT activator, locate on the surface of HDL. CE migrates to the core of the HDL particle. HDL then transports CH from the extrahepatic tissues to the liver. In pigs, casein-feeding as compared to vegetable protein feeding reduced LCAT activity (17) , and thus reduced CH removal and cause CH accumulation in the peripheral tissues. LCAT activity is also affected by dietary fats. Human subjects consumed high saturated fat diet as compared with those ingesting PUFA diets tended to exhibit higher LCAT activity (18) .
Effect of Ditary Proteins and PUFAs on Lipoprotein Metabolism
In rats, soybean protein as compared with casein reduces hepatic secretion of CH and triglyceride (TG), and subsequently hepatic con tribution to lipid-carrying lipoproteins, LDL and VLDL (19) . In rabbits, dietary soy protein signif icantly lowers the levels of apoprotein B associated with LDL, but increases the fractional catabolic rate of VLDL and LDL apo-B (20) . Consumption of an all-plant protein diet also significantly increased the fractional catabolic rate of VLDL apolipoprotein B in hypercholesterolemic men. Dietary PUFAs also lower plasma CH and TG levels. The reduction of plasma CH is attributed to a decreased synthesis of CH for the formation of VLDL particle (21) .
Plasma LDL is removed primarily through tissue LDL receptor that recognizes specific apoproteins (apo B and apo E) in lipoproteins . It has been shown that soybean protein increases LDL receptor activity (22) , while casein-feeding changes CH and protein contents in the LDL fraction and reduced the numbers of hepatic lipoprotein receptors (23) . The effect of dietary PUFAs on LDL receptors is exerted through incorporating into cell membrane phospholipids and modulating the fluidity and function of cell membranes. It has been shown that increasing unsaturation in membrane phospholipids does not affect the number of LDL receptors (24) .
Effect of Dietary Proteins and PUFAs on the Release of Endocrines
Release of hormones, especially insulin and glucagon is regulated by blood amino acid com position. Increasing intake of soy protein, which as compared with casein contains twice amounts of arginine, elevates plasma arginine levels (25) . In rats, casein-feeding increased the fasting insulin levels (26). Sugano and his colleagues have recently reported that the insulin-to-glucagon levels is modulated by the ratios of lysine-to-arginine in dietary protein (27) .
Eicosanoids also regulate the release of hormones. It has been shown that PGE, infusion increases the release of glucagon (28) . Since glucagon inhibits while insulin activates D6D activity , increasing plasma glucagon levels would reduce PUFA metabolism. In addition, glucagon also suppresses the activity of HMG-CoA reductase, and subsequently the CH biosynthesis.
